These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1032427)

  • 1. [Study of the behavior of hepatic function and blood coagulation in the course of oral administration of an estroprogestogen in low dosage].
    Pastore AR; Gaeta A; Police MA
    Riv Ital Ginecol; 1976; 57(3):171-85. PubMed ID: 1032427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the contraceptive efficacy of quingestanol acetate (W 4540) when administered as an oral low-dose conraceptive in the puerperium.
    Moggia AV; Mischler T; Berman E; Beauquis A; Torrrado M; Koremblitt E
    J Reprod Med; 1972 Apr; 8(4):169-73. PubMed ID: 4555282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J
    Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison in changes in blood coagulation tests during use of oral contraceptives. First symposium - sexual steroids].
    Castillo JD; Mendoza C
    Rev Colomb Obstet Ginecol; 1975; 26(1):53-7. PubMed ID: 1144891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The combined effect of an ethinylestradiol/desogestrel contraceptive combination on blood lipids and parameters of liver function and coagulation].
    Massafra C; Capitani S; Bernabei A; Scillone L
    Rev Fr Gynecol Obstet; 1988 Apr; 83(4):251-5. PubMed ID: 2969134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Stone S
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():117-21. PubMed ID: 8260969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK; Maina FW; Kigondu C; Mati JK
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial.
    Friedman AJ; Wheeler J
    J Reprod Med; 1991 Apr; 36(4 Suppl):328-33. PubMed ID: 2046081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
    Spellacy WN; Ellingson AB; Tsibris JC
    J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Veins and contraception].
    Reinharez D; Monsonego J
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K-dependent blood clotting changes in female rats treated with oestrogens.
    Hart JE
    Thromb Haemost; 1987 Jun; 57(3):273-7. PubMed ID: 2821645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with an estro-progestin preparation in low dosage].
    Milano D; Rainer E; Finelli F
    Minerva Ginecol; 1974 Dec; 26(12):762-70. PubMed ID: 4453389
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
    Rákóczi I; Gerö G; Demeter J; Gáti I
    Arzneimittelforschung; 1985; 35(3):630-3. PubMed ID: 3158320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.